NEOGENOMICS INC — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-01-01

Reporting Person: Harris Melody (President, Enterprise Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-01	Common Stock	A	108225	—	Acquired	108225	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-01	Stock Option (Right to Buy)	$9.24	A	201613	Acquired	2030-01-01	Common Stock (201613.0)	Direct

Footnotes

F1: On January 1, 2023, Ms. Harris was granted 108,225 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

F2: On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.